Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
High-affinity IL-2Rα expressed by Tregs mitigates the potential of IL-2 use in cancer therapy. Here, the authors fuse IL-2 with an NKDG2 binding domain, and show that it induces IL-2 signalling selectively in NKG2D+cells, delaying tumour growth in mice without the side effects of conventional IL-2 t...
Main Authors: | Reza Ghasemi, Eric Lazear, Xiaoli Wang, Saeed Arefanian, Alexander Zheleznyak, Beatriz M. Carreno, Ryuji Higashikubo, Andrew E. Gelman, Daniel Kreisel, Daved H. Fremont, Alexander Sasha Krupnick |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2016-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms12878 |
Similar Items
-
Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy
by: Eric Lazear, et al.
Published: (2017-02-01) -
A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement
by: Xiaoli Wang, et al.
Published: (2018-12-01) -
NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Shafiq Murad, et al.
Published: (2022-05-01) -
The role of neutrophil extracellular traps in acute lung injury
by: Davide Scozzi, et al.
Published: (2022-07-01) -
NKG2D
by: O'Callaghan, C
Published: (2009)